Shilpee Dutt

Professor, SLS, JNU

[Shilpee Dutt @DuttShilpee]

Excited! Our latest paper is online in npj Precision Oncology! @Nature_NPJ
Great work by PhD student @Archisman_bnj identifying #BEND4 as novel single-gene prognostic marker and therapeutic target in #AML
Thanks co-authors @ANRFIndia @DBTIndia @ACTREC_TMC
https://t.co/8HmwJOBl3x

[Shilpee Dutt @DuttShilpee]

@amtdutt @Suhail_Shaad @UnivofDelhi @CRI_ACTREC @DBTIndia @TataMemorialCtr @IndiaBioscience @biopatrika @rajesh_gokhale @DrJitendraSingh @Breastcancerorg @BreastCancerNow @BrstCancerNews @BreastCaIndia @AllDUNews Congratulations, Amit, Suhail and the team. Fantastic work with significant translational implications.

[Shilpee Dutt @DuttShilpee]

@MadhuraKetkar @NeuroOnc @desaisanket12 @amtdutt @pranavrana1999 @RahulThorat9769 Congratulations, Madhura for this fantastic work.

[Shilpee Dutt @DuttShilpee]

Thrilled to share that our paper in Neuro-Oncology @NeuroOnc, uncovering the molecular switch driving GBM senescence reversal, is among the most cited recent publications in the field. The science speaks for itself! Congratulations @MadhuraKetkar and all the co-authors

[Madhura Ketkar @MadhuraKetkar]

✨ Our article from my PhD work in @NeuroOnc is the most cited recent publication in the journal- 10 times more cited than average. ✨

Thanks to @DuttShilpee and all the co-authors for their contribution!

[Abhijit Majumder @abhijit_MLab]

@ArpitaGhosh1392 and I will give a joint talk. While I will be talking about our background journey that started with @DuttShilpee lab, Arpita will tell the story of journey forward.

[Shilpee Dutt @DuttShilpee]

The last date for applying to a PhD program at SLS, JNU is tomorrow. Do apply if you are interested in cutting-edge, multidisciplinary research!

[Shilpee Dutt @DuttShilpee]

We will be happy to host NPDF at Shilpee Lab (SLS, JNU). Visit our lab website (https://t.co/m6DrBxMfrw) for research interests and recent publications.

Please write to me with your CV and research interests

[Shilpee Dutt @DuttShilpee]

Thank you @SciSoup for highlighting our findings.
Excellent work by my PhD student, Tejashree, now in Oncogene
@teju1090 @MadhuraKetkar @Archisman_bnj @nileshgardi2688 @biopatrika @Ratnesh_thakur @oncogenejournal

[SciSoup - A Science and Technology Blog @SciSoup]

Scientists Uncover Unusual Cell Division Behind Glioblastoma’s Deadly Comeback

Read more:
🔗https://t.co/A6N5Xyv7Lp
@DuttShilpee @JNU_official_50 @ACTREC_TMC @CRI_ACTREC @Bajaj_RCB @Ratnesh_thakur @SciComm_India @indianscinews #scicomm #scisoup

[Shilpee Dutt @DuttShilpee]

Take a look at our latest article! Superb findings by PhD student Tejashree (@teju1090). Residual #GBM cells divide via #Neosis!
Thank you @ANRFIndia and co-authors @Archisman_bnj @MadhuraKetkar @nileshgardi2688
https://t.co/mvVyFV0qlM

[Department of Biotechnology @DBTIndia]

Apply for a Hands-on #Workshop on Chromatin Modification, Epigenetics and Genetic Regulation organized by the School of Life Sciences, JNU!

#DBT #BUILDER

🔗https://t.co/x51rFyA8ro

@DrJitendraSingh @rajesh_gokhale @JNU_official_50

[Shilpee Dutt @DuttShilpee]

@Chaudhary9Nazia Congratulations, Nazia

[Shilpee Dutt @DuttShilpee]

@CRI_ACTREC Thank you, ACTREC for all the support

[Shilpee Dutt @DuttShilpee]

@Chaudhary9Nazia Congratulations, Nazia!

[Shilpee Dutt @DuttShilpee]

@SyedKHasan1 @ACTREC_TMC @AML_Hub @BloodAdvances @BloodJournal @CRI_ACTREC @TataMemorial Many congratulations, Hasan and team!

[Shilpee Dutt @DuttShilpee]

@DBTIndia @DrJitendraSingh @rajesh_gokhale Thank you, @DBTIndia for funding this research and for the recognition of our work.

[Shilpee Dutt @DuttShilpee]

Thank you @DBTIndia for highlighting our study. Indeed, inhibition of PERK mediated UPR provides a much-needed seno-therapeutic option in the most aggressive brain tumor (glioblastoma). https://t.co/BDaXahRTgN @MadhuraKetkar @CRI_ACTREC @ACTREC_TMC @amtdutt

[Department of Biotechnology @DBTIndia]

Research from the lab of @DuttShilpee aims to delineate the #TIS reversal mechanism in glioblastoma #GBM recurrence. The study provide evidence of a novel senolytic drug offering a new seno-therapeutic option for eliminating residual GBM & preventing recurrence.

@DrJitendraSingh

[Shilpee Dutt @DuttShilpee]

@subir_biswas88 @CMLSjournal @debashmitasark5 @amartya_acad @SHAINAMANDI @DBTIndia @ANRFIndia @ACTREC_TMC @CRI_ACTREC Thanks, Subir

[Shilpee Dutt @DuttShilpee]

Happy to share our latest paper in @CMLSjournal. This impressive study, PhD work of @debashmitasark5 provides mechanistic details of GCN5 function at DSBs. Thanks @amartya_acad @shainamandi. Thanks @DBTIndia @ANRFIndia @ACTREC_TMC @CRI_ACTREC for support
https://t.co/KMg2bB6b0q

[Shilpee Dutt @DuttShilpee]

@Ella_Maru @CMLSjournal @debashmitasark5 @amartya_acad @SHAINAMANDI @DBTIndia @ANRFIndia @ACTREC_TMC @CRI_ACTREC Thank you

[Shilpee Dutt @DuttShilpee]

@ShilpySharma14 @CMLSjournal @debashmitasark5 @amartya_acad @SHAINAMANDI @DBTIndia @ANRFIndia @ACTREC_TMC @CRI_ACTREC Thank you, Shilpy

[Shilpee Dutt @DuttShilpee]

@DeepakNModi @CMLSjournal @debashmitasark5 @amartya_acad @SHAINAMANDI @DBTIndia @ANRFIndia @ACTREC_TMC @CRI_ACTREC Thanks, Deepak